Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911042620> ?p ?o ?g. }
- W2911042620 abstract "Campylobacter spp. may cause fever, vomiting, and diarrhea in humans. Antibiotic treatment is suggested for patients with severe campylobacteriosis. However, the interpretative criteria for antibiotic susceptibility are inconsistent between Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines. The aim of the study is to investigate the antibiotic susceptibility and prevalence of cytolethal distending toxin genes and to evaluate antibiotic susceptibility testing methods in the clinical laboratories of two tertiary medical centers in Taiwan. In total, 236 bacterial isolates were collected between 2001 and 2014. The disk diffusion and E-test methods were used to evaluate the antibiotic susceptibility, and broth dilution results were used as a reference. The virulence genes cdtA, cdtB, cdtC, and ceuE were detected through polymerase chain reaction. The antimicrobial sensitivity rates for erythromycin, ciprofloxacin, and tetracycline using the broth dilution assay were 80.4, 5.4, and 3.4%, respectively. No significant differences were observed in the antibiotic susceptibility of the isolates obtained from southern and northern Taiwan. However, some differences were observed between species. The susceptibility test for erythromycin (disk diffusion) showed that the isolates with small inhibition zone diameters were all resistant, and five isolates (4.0%) with large IZDs were non-sensitive. The error rate of the disk diffusion method according to the CLSI M45-A3 guideline was 5.4% (8/148). The incompatibility rates between the E-test and broth dilution methods for erythromycin, ciprofloxacin, and tetracycline were 8.0, 5.3, and 1.3%, respectively. The positive rates of the genes cdtA and cdtC were considerably higher in Campylobacter jejuni than in C. coli. Erythromycin is recommended as the first choice of treatment for campylobacteriosis. The disk diffusion method is suitable for prescreening Campylobacter susceptibility by using the CLSI M45-A2 and EUCAST criteria (low error rate of 3.4%). If antibiotic treatment fails or IZDs are between 6 and 20 mm, minimum inhibitory concentration testing by using the E-test method is highly recommended because the results of the E-test and broth dilution methods exhibit high agreement. The error rate of disk diffusion method using CLSI M45-A3 criteria is only slightly higher than B, which is also a suitable criteria." @default.
- W2911042620 created "2019-01-25" @default.
- W2911042620 creator A5005979032 @default.
- W2911042620 creator A5016909327 @default.
- W2911042620 creator A5024441418 @default.
- W2911042620 creator A5035668522 @default.
- W2911042620 creator A5040170945 @default.
- W2911042620 creator A5050593719 @default.
- W2911042620 date "2019-01-07" @default.
- W2911042620 modified "2023-10-17" @default.
- W2911042620 title "Antimicrobial Susceptibility and Virulence Surveillance of Campylobacter spp. Isolated From Patients in Two Tertiary Medical Centers in Taiwan" @default.
- W2911042620 cites W1600433175 @default.
- W2911042620 cites W1755824933 @default.
- W2911042620 cites W1849301422 @default.
- W2911042620 cites W1945721024 @default.
- W2911042620 cites W1996518446 @default.
- W2911042620 cites W2006317720 @default.
- W2911042620 cites W2048685517 @default.
- W2911042620 cites W2074092251 @default.
- W2911042620 cites W2079617293 @default.
- W2911042620 cites W2087193563 @default.
- W2911042620 cites W2108855616 @default.
- W2911042620 cites W2124226882 @default.
- W2911042620 cites W2127214408 @default.
- W2911042620 cites W2178216940 @default.
- W2911042620 cites W2277291735 @default.
- W2911042620 cites W2344184808 @default.
- W2911042620 cites W2394925141 @default.
- W2911042620 cites W2409469804 @default.
- W2911042620 cites W2424706609 @default.
- W2911042620 cites W2462228944 @default.
- W2911042620 cites W2466126517 @default.
- W2911042620 cites W638920985 @default.
- W2911042620 doi "https://doi.org/10.3389/fmicb.2018.03186" @default.
- W2911042620 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6330319" @default.
- W2911042620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30666236" @default.
- W2911042620 hasPublicationYear "2019" @default.
- W2911042620 type Work @default.
- W2911042620 sameAs 2911042620 @default.
- W2911042620 citedByCount "4" @default.
- W2911042620 countsByYear W29110426202021 @default.
- W2911042620 countsByYear W29110426202022 @default.
- W2911042620 crossrefType "journal-article" @default.
- W2911042620 hasAuthorship W2911042620A5005979032 @default.
- W2911042620 hasAuthorship W2911042620A5016909327 @default.
- W2911042620 hasAuthorship W2911042620A5024441418 @default.
- W2911042620 hasAuthorship W2911042620A5035668522 @default.
- W2911042620 hasAuthorship W2911042620A5040170945 @default.
- W2911042620 hasAuthorship W2911042620A5050593719 @default.
- W2911042620 hasBestOaLocation W29110426201 @default.
- W2911042620 hasConcept C11636898 @default.
- W2911042620 hasConcept C176947019 @default.
- W2911042620 hasConcept C2777858656 @default.
- W2911042620 hasConcept C2778512257 @default.
- W2911042620 hasConcept C2779910956 @default.
- W2911042620 hasConcept C2780104969 @default.
- W2911042620 hasConcept C2780206985 @default.
- W2911042620 hasConcept C2780493024 @default.
- W2911042620 hasConcept C2780923616 @default.
- W2911042620 hasConcept C501593827 @default.
- W2911042620 hasConcept C523546767 @default.
- W2911042620 hasConcept C54355233 @default.
- W2911042620 hasConcept C86803240 @default.
- W2911042620 hasConcept C89423630 @default.
- W2911042620 hasConcept C94665300 @default.
- W2911042620 hasConceptScore W2911042620C11636898 @default.
- W2911042620 hasConceptScore W2911042620C176947019 @default.
- W2911042620 hasConceptScore W2911042620C2777858656 @default.
- W2911042620 hasConceptScore W2911042620C2778512257 @default.
- W2911042620 hasConceptScore W2911042620C2779910956 @default.
- W2911042620 hasConceptScore W2911042620C2780104969 @default.
- W2911042620 hasConceptScore W2911042620C2780206985 @default.
- W2911042620 hasConceptScore W2911042620C2780493024 @default.
- W2911042620 hasConceptScore W2911042620C2780923616 @default.
- W2911042620 hasConceptScore W2911042620C501593827 @default.
- W2911042620 hasConceptScore W2911042620C523546767 @default.
- W2911042620 hasConceptScore W2911042620C54355233 @default.
- W2911042620 hasConceptScore W2911042620C86803240 @default.
- W2911042620 hasConceptScore W2911042620C89423630 @default.
- W2911042620 hasConceptScore W2911042620C94665300 @default.
- W2911042620 hasFunder F4320309618 @default.
- W2911042620 hasFunder F4320313619 @default.
- W2911042620 hasLocation W29110426201 @default.
- W2911042620 hasLocation W29110426202 @default.
- W2911042620 hasLocation W29110426203 @default.
- W2911042620 hasLocation W29110426204 @default.
- W2911042620 hasLocation W29110426205 @default.
- W2911042620 hasOpenAccess W2911042620 @default.
- W2911042620 hasPrimaryLocation W29110426201 @default.
- W2911042620 hasRelatedWork W2009436508 @default.
- W2911042620 hasRelatedWork W2036010871 @default.
- W2911042620 hasRelatedWork W2075478742 @default.
- W2911042620 hasRelatedWork W2161202368 @default.
- W2911042620 hasRelatedWork W2178259466 @default.
- W2911042620 hasRelatedWork W2522131451 @default.
- W2911042620 hasRelatedWork W3094141480 @default.
- W2911042620 hasRelatedWork W3213147472 @default.
- W2911042620 hasRelatedWork W4323843757 @default.
- W2911042620 hasRelatedWork W4379035101 @default.
- W2911042620 hasVolume "9" @default.